Zeroace-SR Tablet contains Aceclofenac 200 mg, a non-steroidal anti-inflammatory drug (NSAID) indicated for the management of pain and inflammation associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Aceclofenac exerts its therapeutic effect by selectively inhibiting cyclooxygenase (COX), thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and fever. The sustained-release formulation of Zeroace-SR ensures a prolonged duration of action, allowing for once or twice-daily dosing, which enhances patient compliance and provides consistent symptom control. This medication is particularly beneficial in alleviating joint pain, swelling, and stiffness, improving overall mobility and quality of life in affected individuals. Zeroace-SR should be administered with food to minimize gastrointestinal discomfort, a common adverse effect associated with NSAIDs. Caution is advised in patients with a history of peptic ulcer disease, cardiovascular disorders, renal or hepatic impairment, and those on concomitant anticoagulant therapy. Regular monitoring is recommended during prolonged use. Contraindications include hypersensitivity to aceclofenac or other NSAIDs, active gastrointestinal bleeding, and third-trimester pregnancy. Zeroace-SR Tablet should be used under medical supervision to ensure optimal therapeutic outcomes and minimize potential risks.